Review of Nanobiopolymers for Controlled Drug Delivery

Polymer - Plastics Technology and Engineering

Volumn 53, Issue 15, 2014, Pages 1636-1646

  Saranya, S ^a   Radha, K V ^a  

^a ANNA UNIVERSITY   (India)

Author keywords

Chitosan; Encapsulation; Gelatin; Polyhydroxyalkaonaote; Polylactic acid; Polymeric nanoparticles

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; CHITOSAN; ENCAPSULATION; GENE THERAPY; NANOPARTICLES; POLYESTERS; PROTEINS; TARGETED DRUG DELIVERY;

BIODEGRADABLE POLYMERIC NANOPARTICLES; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE SYSTEMS; GELATIN; POLY LACTIC ACID; POLY LACTIC-CO-GLYCOLIC ACID; POLYHYDROXYALKAONAOTE; POLYMERIC NANOPARTICLES;

CONTROLLED DRUG DELIVERY;

EID: 84908205261     PISSN: 03602559     EISSN: 15256111     Source Type: Journal    
DOI: 10.1080/03602559.2014.915035     Document Type: Review

References (119)

1. Morachis , J.M. ; Mahmoud , E.A. ; Almutairi , A. Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles . Pharmacol. Rev. 2012 , 64 , 505 – 519.
2. Lanbger , R. Biomaterials in drug delivery and tissue engineering . Acc. Chem. Res. 2000 , 33 , 94 – 101 .
3. Agrawal , R. ; Shanavas , A. ; Yadav , S. ; Aslam , M. Polyelectrolyte coated polymeric nanoparticles for controlled release of doxetaxel . J. Biomed. Nanotechnol. 2012 , 8 , 19 – 28 .
4. Budhian , A. ; Seigel , S.J. ; Winey , K.L. Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol . J. Microencapsul. 2005 , 22 , 773 – 785 .
5. Cheng , Q. ; Feng , J. ; Chen , J. ; Zhu , X. ; Lu , F. Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study . Biopharm. Drug Dispos. 2008 , 29 , 431 – 439 .
6. Mu , L. ; Feng , S.S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS . J. Control. Rel. 2003 , 86 , 33 – 48 .
7. Coester , C. ; Kreuter , J. ; Von Briesen , H. ; Langer , K. Preparation of avidin-labelled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA) . Int. J. Pharm. 2000 , 196 , 147 – 149 .
8. Damge , C. ; Maincent , P. ; Ubrich , N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats . J. Control. Rel. 2007 , 117 , 163 – 170 .
9. Date , A.A. ; Joshi , M.D. ; Patravale , V.B. Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles . Adv. Drug Deliv. Rev. 2007 , 59 , 505 – 521 .
10. Mandalina , G.F. ; Ioan Avram , N. ; Camelia , U. ; Anton , F. ; Denisa , F. ; Cornelia , G. ; Ecaterina , A. Alginate and sulfanilamide based DDS with antibacterial activity . Int. J. Polym. Mater. Polym. B. Mater. 2014 , 63 , 92 – 96 .
11. Kim , S.Y. ; Lee , Y.M. Taxol-loaded block copolymer nanospheres composed of methoxy poly (ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers . Biomaterials. 2001 , 22 , 1697 – 1704 .
12. Lee , K.S. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer . Breast Cancer Res. Treat. 2008 , 108 , 241 – 250 .
13. Vlerken , L.E. ; Vyas , T.K. ; Amiji , M.M. Poly (ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery . Phama. Res. 2007 , 24 , 1405 – 1414 .
14. Brannon-Peppas , L.; Blanchette , J.O.Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev.2004, 56, 1649–1659.
15. Feng , S.S. Nanoparticles of biodegradable polymers for new-concept chemotherapy . Expert Rev. Med. Devices 2004 , 1 , 115 – 125 .
16. Shenoy , D.B. ; Amiji , M.M. Poly (ethylene oxide)-modified poly (epsiloncaprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer . Int. J. Pharm. 2005 , 293 , 261 – 270 .
17. Brigger , I. ; Dubernet , C. ; Couvreur , P. Nanoparticles in cancer therapy and diagnosis . Adv. Drug Deliv. Rev. 2002 , 54 , 631 – 651 .
18. Dhandayuthapani , B. Polymeric scaffolds in tissue engineering application: A Review . Int. J. Poly. Sci. 2011 , 20 , 1 – 19 .
19. Pinto Reis , C. ; Neufeld , R.J. ; Ribeiro , A.J. Nanoencapsulation I. Methods for preparation of drug loaded polymeric nanoparticles . J. Nanomed. 2006 , 2 , 8 – 21 .
20. Panyam , J. ; Labhasetwar , V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue . Adv. Drug Deliv. Rev. 2003 , 55 , 329 – 347 .
21. Locatelli , E. ; Franchini , M.C. Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery system . J. Nanopart. Res. 2012 , 14 , 1316 – 1340 .
22. Asadi , H. ; Rostamizadeh , K. ; Salari , D. Preparation of biodegradable nanoparticle of triblock PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial network . J. Microencapsul. 2011 , 28 , 406 – 416 .
23. Nagavarma , B.V.N. ; Hemant , K.S. ; Yadav, Ayaz , A. ; Vasudha , L.S. Different techniques for preparation of polymeric nanoparticles- a review . A. J. Pharm. Clin. Res. 2012 , 5 , 2 – 13 .
24. Shah , M. ; Naseer , M.I. ; Choi , M.H. Amphilic PHA-m PEG CoPolymeric nanocontainers for drug delivery: Preparation, Characterisation and invitro evaluation . Int. J. Pharm. 2010 , 400 , 165 – 175 .
25. Jelvehgari , M. ; Barar , J. ; Valizadeh , H. Preparation and evaluation of poly (capro lactone) nanoparticles by W/O/W emulsion method . Iran. J Basic Med. Sci. 2010 , 13 , 85 – 96 .
26. Ige , P.P. ; Gattani , S.S. Development of low density microspheres of metformin hydrochloride using ethyl cellulose and HPMC K4M: invitro and invivo characterization . Polym.-Plast. Technol. Eng. 2012 , 51 , 1537 – 1544 .
27. Pinon Segundo , E. ; Nava Arzalu , M.G. ; Lechuga Ballesteros , D. Pharmaceutical polymeric nanoparticles prepared by the double emulsion solvent evaporation technique . Recent Pat. Drug Deliv Formul. 2012 , 224 – 235 .
28. Birnbaum , D.T. ; Kosmala , J.D. ; Henthorn , D.B. ; Peppas , L.B. ; Soppimath , K.S. Controlled release of beta estradiol from PLAGA microparticles . J. Control. Rel. 2001 , 70 , 1 – 20 .
29. Hao , S. ; Wang , B. ; Wang , Y. ; Zhu , L. Preparation of Eudragit L100-55 enteric nanoparticles by a novel emulsion diffusion method . Coll. Surf. B Biointerfaces 2013 , 108 , 127 – 133 .
30. Liu , J. ; Qui , Z. ; Wang , S. ; Zhou , L. A modified double emulsion method for the preparation of daunorubicin loaded polymeric nanoparticle with enhanced in vitro antitumour activity . Biomed. Mater. 2010 , 5 , 1 – 20 .
31. Galindo-Rodriguez , S. ; Allemann , E. Physicochemical parameters associated with nanoparticle formation in the salting out emulsification diffusion and nanoprecipitation methods . Pharm. Res. 2004 , 21 , 1428 – 1439 .
32. Krishna Sailaja , A. ; Amareshwar , P. ; Jayaprakash , D. Preparation and characterization of nimesulide loaded cellulose acetate hydrogen phthalate nanoparticles by salting out technique . World J. Pharm. Sci. 2013 , 1 , 21 – 27 .
33. Amolkumar , B. ; Lokhande . Preparation and characterization of repaglinide loaded ethylcellulose nanoparticles by solvent diffusion technique using high pressure homogenizer . J. Pharm. Res. 2013 , 7 , 421 – 426 .
34. Leimann , F.V. ; Cardozofitho , L. ; Sayer , C. Poly (3hydroxy co 3hydroxy valerate) nanoparticles prepared by a miniemulsion solvent evaporation technique- effect of PHBV molar mass and concentration . Brazil. J. Chem. Engg. 2013 , 30 , 369 – 377 .
35. Mudgi , M. ; Gupta , N. ; Nagpal , M. ; Pawar , P. Nanotechnology: a new approach for ocular drug delivery system . Int. J. Pharm. Pharm. Sci. 2012 , 4 , 105 – 112 .
36. Yordanov , G. Poly alkyl cyanoacrylate nanoparticles as drug carriers . Bulg. J. Chem. 2012 , 1 , 61 – 73 .
37. Nicolas , J. ; Vauthier , C. Poly alkyl cyano acrylate nanosystems for intracellular delivery . Fund. Biomed. Tech. 2011 , 5 , 225 – 250 .
38. Couvreur , P. ; Kante , B. ; Roland , M. Les perspectives d'utilisa’comme intraceltion des formes microdisperses vecteurs lulaires . Pharm. Acta Helv. 1978 , 53 , 341 – 347 .
39. Couvreur , P. ; Kante , B. ; Roland , M. ; Goit , P. ; Bauduin , P. ; Speiser , P. Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphology and sorptive properties . J. Pharm. Pharmacol. 1979 , 31 , 331 – 332 .
40. Verderio , P. ; Bonetti , P. ; Colombo , M. Intracellular drug release from curcumin loaded PLGA nanoparticles induces G2/M block in breast cancer cells . Biomacromolecules 2013 , 14 , 672 – 682 .
41. Sahana , D.K. PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug . J. Pharm. Sci. 2008 , 97 , 1530 – 1542 .
42. Danhier , F. ; Ansorena , E. ; Silva , J.M. ; Coco , R. ; Le Breton , A. ; Preat , V. PLGA based nanoparticles: An overview of biomedical applications . J. Control. Rel. 2012 , 161 , 505 – 522 .
43. Averineni , R.K. ; Shavi , G.V. ; Gurram , A.K. PLGA 50:50 nanoparticles of paclitaxel development invitro antitumour activity in BT 549 cells and invivo evaluation . Bull. Mater. Sci. 2012 , 35 , 319 – 326 .
44. Carrasquillo , K.G. Non-aqueous encapsulation of excipient-stabilized spray-freeze dried BSA into poly (lactide-co-glycolide) microspheres results in release of native protein . J. Control. Rel. 2001 , 76 , 199 – 208 .
45. Soppimath , K.S. ; Tejraj , M. ; Anandrao , R. ; Walter , E. Biodegradable polymeric nanoparticles as drug delivery devices . J. Cont. Rel. 2001 , 70 , 1 – 20 .
46. Thamilselvi , V. ; Radha , K.V. Synthesis of silver nanoparticles from Pseudomonas putida NCIM 2650 in silver nitrate supplemented growth medium and optimization using response surface methodology . Digest. J. Nanomater. Biostruct. 2013 , 8 , 1101 – 1111 .
47. Mittal , G. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo . J. Control. Rel. 2007 , 119 , 77 – 85 .
48. Hirenkumar , K. Poly lactic co glycolic acid (PLGA) as biodegradable controlled drug delivery carrier . Control. Drug Deliv. Carr. 2011 , 3 , 1377 – 1397 .
49. Kumar , M.N. Cationic poly (lactide-co-glycolide) nanoparticles as efficient in vivo gene transfection agents . J. Nanosci. Nanotechnol. 2004 , 4 , 990 – 994 .
50. Mundargi , R.C. ; Babu , V.R. ; Rangaswamy , V. ; Patel , P. Nano/micro technologies for delivering macromolecular therapeutics using poly (d,l-lactide-co-glycolide) and its derivatives . J. Control. Rel. 2008 , 125 , 193 – 209 .
51. Zeng , X. ; Tao , W. ; Mei , L. ; Huang , L. Cholic acid functionalized nanoparticles of star shaped PLGA vit E TPGS copolymer for docetaxel delivery to cervical cancer . Biomaterials. 2013 , 25 , 6058 – 6067 .
52. Fonseca , C. ; Simoes , S. ; Gaspar , R. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity . J. Control. Rel. 2002 , 83 , 273 – 286 .
53. Avgoustakis , K.PLGA–mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Contr. Rel.2002, 79, 123–135.
54. Li , W. ; Wang , X. ; Wang , K. ; Chen , T. ; Chen , X. ; Niu , X. A novel of biodegradable implants based on PLGA for control delivery of cisplatin . Int. J. Polym. Mater. Polym. B Mater. 2014 , 63 , 368 – 373 .
55. Leo , E. In vitro evaluation of PLA nanoparticles containing a lipophilic drug in water-soluble or insoluble form . Int. J. Pharm. 2004 , 278 , 133 – 141 .
56. Pinto , M.M. ; Sousa , E.P. Natural and synthetic xanthonolignoids: chemistry and biological activities . Curr. Med. Chem. 2003 , 10 , 1 – 12 .
57. Teixeira , M. ; Alonso , M.J. ; Pinto , M.M. ; Barbosa , C.M. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone . Eur. J. Pharm. Biopharm. 2005 , 59 , 491 – 500 .
58. 3composites prepared by sol-gel process . Polym.-Plast. Technol. Eng. 2013 , 52 , 1488 – 1495 .
59. Kamaly , N. ; Xiao , Z. Targeted polymeric therapeutic nanoparticle design, development and clinical translation . Chem. Soc. Rev. 2012 , 41 , 2971 – 3010 .
60. Ikezoe , T. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways . Mol. Cancer Ther. 2005 , 4 , 578 – 586 .
61. Xing , J. ; Zhang , D. ; Tan , T. Studies on the oridonin-loaded poly (d,l-lactic acid) nanoparticles in vitro and in vivo . Int. J. Biol. Macromol. 2007 , 40 , 153 – 158 .
62. Gao , H. ; Wang , Y.N. ; Fan , Y.G. Synthesis of a biodegradable tadpole-shaped polymer via the coupling reaction of polylactide onto mono (6-(2-aminoethyl)amino-6-deoxy)-beta-cyclodextrin and its properties as the new carrier of protein delivery system . J. Control. Release. 2005 , 107 , 158 – 173 .
63. Gao , H. Cyclodextrin and its properties as the new carrier of protein delivery system . J. Control. Rel. 2005 , 107 , 158 – 173 .
64. Sailaja , K.A. ; Amareshwar , P. ; Chakravathy , P. Chitosan nanoparticles as a drug delivery system . Research J. Pharm. Biol. Chem. Sci. 2010 , 1 , 474 – 484 .
65. Pan , Y. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo . Int. J. Pharm. 2002 , 249 , 139 – 147 .
66. Weizhang , J. The hypolipidemic activity of chitosan nanopowder prepared by ultrafine milling . Carbohydr. Polymers. 2013 , 951 , 487 – 491 .
67. Janes , K.A. Chitosan nanoparticles as delivery systems for doxorubicin . J. Control. Rel. 2001 , 73 , 255 – 267 .
68. Cho , Y. Chitosan nanoparticle based neuronal membrane sealing and neuroprotection following acrolein induced cell injury . J. Biol. Engg. 2010 , 4 , 1 – 11 .
69. Sonia , T.A. ; Chandra , P. Chitosan and its derivatives for drug delivery perspective . Adv. Polym. Sci. 2011 , 243 , 23 – 54 .
70. Kumar , S. ; Kumari , M. ; Dutt , P.K. ; Koh , J. Chitosan biopolymer Schiff base: preparation, characterization, optical and antibacterial activity . Int. J. Polym. Mater. Polym. B Mater. 2013 , 63 , 173 – 177 .
71. Sato , H. ; Ogawa , K. ; Kojo , Y. ; Kawabata , Y. Development of cyclosporine A-loaded dry emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy . International J. Pharmaceutics. 2013 , 448 , 282 – 289 .
72. De Campos , A.M. ; Sanchez , A. ; Alonso , M.J. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface application to cyclosporin A . Int. J. Pharm. 2001 , 208 , 159 – 168 .
73. Kaur , A. ; Jain , S. ; Tiwary , A.K. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation . Acta Pharm. 2008 , 58 , 61 – 74 .
74. Bajpai , A.K. ; Choubey , J. Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate . J. Mater. Sci. Mater. Med. 2006 , 17 , 345 – 358 .
75. Davis , S. Drug delivery systems . Interdisc. Sci. Rev. 2000 , 25 , 175 – 183 .
76. Zhang , L. Development of nanoparticles for antimicrobial drug delivery . Curr. Med. Chem. 2010 , 17 , 585 – 594 .
77. Mora , C.E. Polymer based nanocapsule for drug delivery . Inter. J. Pharmaceut. 2010 , 385 , 113 – 142 .
78. Yang , A. ; Liu , W. ; Li , Z. ; Jiang , L. Influence of polyethylene glycol modification on phagocytic uptake of polymeric nanoparticles mediated by immunoglobulin G and complement activation . J. Nanosci. Nanotechnol. 2010 , 10 , 622 – 628 .
79. Owens , D.E. ; Peppas , N.A. Opsonization, biodistribution and pharmacokinetics of polymeric nanoparticles . Inter. J. Pharmaceut. 2006 , 307 , 93 – 102 .
80. Allemann , E. ; Patricia , J.C. ; Luc , B. ; Gurnay , R. Kinetics of blood component-adsorption on poly (D,L-lactide) nanoparticles: Evidence of compliment C 3 component involvement . J. Biomed. Mater. Res. 1997 , 37 , 229 – 234 .
81. Blunk , T. ; Luck , M. ; Calvoer , M. ; Hochstrasser , D.F. ; Sanchez , J.C. ; Muller , B.W. ; Muller , R.H. Kinetics of plasma protein adsorption on model particles for controlled drug delivery and drug targeting . Eur. J. Pharm. Biopharm. 1996 , 42 , 262 – 268 .
82. Gref , R. ; Domb , A. ; Quellec , P. ; Blunk , T. ; Muller , R. H. ; Verbavatz , R. M. ; Langer , R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres . Adv. Drug Deliv. Rev. 1995 , 26 , 215 – 233 .
83. Analiza Povrine Polimerov , Z. Surface characterization of polymers by XPS and SIMS technique . Materials and Technology. 2011 , 45 , 191 – 197 .
84. Shen , J.M. ; Yin , T. ; Tian , X. Surface charge switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug . Appl. Mater. Interf. 2013 , 5 , 7014 – 7024 .
85. Gref , R. ; Minamitake , Y. ; Peracchia , M.T. ; Trubetskoy , V. ; Langer , R. Biodegradable long-circulating polymeric nanoparticles . Science 1994 , 263 , 1600 – 1603 .
86. Peracchia , M.T. ; Harnisch , S. ; Pinto-Alphandary , H. ; Gulik , A. ; Dedieu , J.C. ; Desmaele , D. ; d'Angelo , J. ; Muller , R.H. ; Couvreur , P. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles . Biomaterials 1999 , 20 , 1269 – 1275 .
87. Joen , S.I. ; Lee , J.H. ; Andrade , J.D. ; Gennes , J. Protein-surface interactions in the presence of polyethylene oxide. I. Simplified theory . Coll. Interf. Sci. 1991 , 42 , 149 – 158 .
88. Bazile , D. ; Prudhomme , C. ; Bassoullet , M.-T. ; Marlard , M. ; Spenlehauer , G. ; Veillard , M. Stealth Me-PEG – PLA nanoparticles avoid uptake by the mononuclear phagocyte system . J. Pharm. Sci. 1995 , 84 , 493 – 498 .
89. Tobio , M. ; Gref , R. ; Sanchez , A. ; Langer , R. ; Alonso , M.T. Stealth PLA – PEG nanoparticles as protein carriers for nasal administration . Pharm. Res. 1998 , 15 , 270 – 275 .
90. Gref , R. ; Miralles , G. ; Dellacherie , E. Polyoxyethylene coated nanospheres: effect of coating on zeta potential and phagocytosis . Polymer Int. 1999 , 48 , 251 – 256 .
91. Govender , T. ; Riley , T. ; Stolnik , S. ; Garnett , M.S. ; Illum , L. ; Davis , S.S. PLA–PEG nanoparticles for site specific delivery: drug incorporation studies . J. Control. Rel. 2000 , 62 , 269 – 347 .
92. Kim , S.Y. ; Shin , I.G. ; Lee , Y.M. Preparation and characterization of biodegradable nanospheres composed of methoxy poly (ethylene glycol) and DL-lactide block copolymer as novel drug carriers . J. Control. Rel. 1998 , 56 , 197 – 208 .
93. Peracchia , M.T.; Fattal , E.; Desmaele , D.; Bensard , M.; Noel , J.P.; Gomis , J.M.; Appel , M.; Couvreur , P. J.PEGylated polycyanoacrylate nanoparticles for intravenous administration and spleenic targeting. Control. Rel.1999, 60, 121–128.
94. Gessnerl , A. ; Paulke , B.R. ; Muller , R.H. Plasma protein adsorption on poly(ethylene-glycol) (PEG) modified polystyrene nanoparticles: influence of PEG surface density . Control. Rel. Bioact. Mater. 1999 , 26 , 597 – 598 .
95. Peracchia , M.T. ; Gref , R. ; Minamitake , Y. ; Domb , A. ; Langer , J. PEG-coated injectable nanospheres prepared from amphiphilic diblock and multiblock copolymers: investigation of drug encapsulation and release characteristics . Control. Rel. 1997 , 46 , 223 – 231 .
96. Jaeghere , F.D. ; Allemann , E. ; Leroux , J.C. ; Stevels , W. ; Feijen , J. ; Doelker , E. ; Gurny , R. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: Influence on the physical stability and in vitro cell uptake . Pharm. Res. 1999 , 16 , 859 – 866 .
97. Vittaz , M. ; Razile , D. ; Spenlehauer , G. ; Verrecchia , T. ; Veillard , M. ; Puisieux , F. ; Labarre , D. Effect of PEO surface density on long-circulating PLA –PEO nanoparticles which are very low complement activators . Biomaterials. 1996 , 17 , 1575 – 1581 .
98. Storm , S. ; Belliot , S.O. ; Daemen , T. ; Lasic , D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear system . Adv. Drug Deliv. Rev. 1995 , 17 , 31 – 48 .
99. Illum , L. ; Davis , S.S. Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration . J. Pharm. Sci. 1983 , 72 , 1086 – 1089 .
100. Illum , L. ; Davis , S.S. The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (poloxamer 338) . FEBS Letts. 1984 , 167 , 79 – 82 .
101. Rudt , S. ; Muller , R.H. Invitro phagocytosis assay of nano and microparticles by chemiluminescence, uptake of differently sized surface modified particles and its correlation to particle properties and in vivo distribution . Eur. J. Pharm. Sci. 1993 , 1 , 31 – 39 .
102. Illum , L. ; Davis , S.S. ; Muller , R.H. ; Mak , P. Colloidal carriers stabilized with a block copolymer poloxamine . Int. J. Pharm. 1993 , 89 , 25 – 31 .
103. Cho , C.S. ; Jeong , Y.I. ; Ishihara , T. ; Takei , R. ; Park , J.U. ; Park , K.H. ; Maruyama , A. ; Akaike , T. Simple preparation of nanoparticles coated with carbohydrate carrying polymers . Biomaterials 1997 , 18 , 323 – 326 .
104. Duchene , D. ; Wouessidjewe , D. ; Ponchel , G. Cyclodextrins and carrier systems . J. Contr. Rel. 1999 , 62 , 263 – 268 .
105. Chandrasekhar , R. ; Bonepally , S. ; Gandey , J. Preparation, characterization and invivo evaluation of silybin nanoparticles for the treatment of liver fibrosis . Trop. J. Pharmaceut. Res. 2013 , 12 , 1 – 6 .
106. Couvreur , P. ; Puiseux , F. Nano and microparticles for the delivery of peptides and proteins . Adv. Drug Deliv. Rev. 1993 , 5 , 141 – 162 .
107. Uchida , T. ; Yagi , A. ; Oda , Y. ; Dakada , Y. ; Goto , S. Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres . Chem. Pharm. Bull. 1996 , 44 , 235 – 236 .
108. Lin , J.K. ; Wang , N. ; Wu , X.S. A novel biodegradable system based on gelatin NPs and poly (lactic-co-glycolic acid) microspheres for protein and peptide drug delivery . J. Pharm. Sci. 1997 , 86 , 891 – 895 .
109. Wang , N. ; Wu , X.S. ; Li , J.K. A heterogeneously structured composite based on poly (lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long term protein drug delivery . Pharm. Res. 1990 , 16 , 1430 – 1435 .
110. Gasper , R.M.M. ; Blanco , D. ; Cruz , M.E. ; Alonso , M.J. Formulation of L-asparginase loaded poly(lactide-co-glycolide) nanoparticles; influence of polymer properties on enzyme loading, activity and invitro release . J. Control. Rel. 1998 , 52 , 53 – 62 .
111. Fishbein , I. ; Chorny , M. ; Rabinovich , L. ; Banai , S. ; Gati , I. ; Golomb , G. Nanoparticulate delivery system of a tyrphostin for the treatment of restenosis . J. Control. Rel. 2000 , 65 , 221 – 229 .
112. Kawashima , Y. ; Yamamoto , H. ; Takeuchi , H. ; Fujioka , S. ; Hino , T. Pulmonary delivery of insulin with nebulized Dlactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect . J. Control. Rel. 1999 , 62 , 279 – 287 .
113. Carino , G.P. ; Jacob , J.S. ; Mathiowitz , E. Nanosphere based oral insulin delivery . J. Control. Rel. 2000 , 65 , 261 – 269 .
114. Alyautdin , R.N. ; Tezikov , E.B. ; Ramga , P. ; Kharkevich , D.A. ; Begley , D.J. ; Kreuter , J. Significant entry of tubocurarin into the brain of rats by adsorption to polysorbate 80 coated polybutylcyanoacrylate nanoparticles: insitu brain perfusion study . J. Microencapsul. 1999 , 15 , 67 – 74 .
115. Kharkevich , J. ; Kreuter . Delivery of lopermide across the blood brain barrier with polysorbate 80- coated Polybutylcyanoacrylate nanoparticles . Pharm. Res. 1997 , 14 , 25 – 328 .
116. Leavy , M.Y. ; Benita , S. Drug release from submicron O/W emulsion: A new invitro kinetic evaluation model . Int. J. Pharm. 1990 , 66 , 29 – 37 .
117. Calvo , P. ; Vila-Jato , J.L. ; Alonso , M.J. Comparative invitro evaluation of several colloidal systems, nanoparticles, nanocapsules and nanoemulsions as ocular drug carriers . J. Pharm. Sci. 1996 , 85 , 530 – 536 .
118. Polakovic , M. ; Gorner , T. ; Gref , R. ; Dellacherie , E. Lidocaine loaded biodegradable nanospheres, modeling of drug release . J. Control. Rel. 1999 , 60 , 169 – 177 .
119. Lu , Z. ; Bei , J. ; Wang , S. A method of the preparation of polymeric nanocapsules without stabilizer . J. Control. Rel. 1999 , 61 , 107 – 122 .